Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand) https://validator.w3.org/feed/docs/rss2.html Enhancing T cell cytotoxicity against lung cancer with an αPD-L1 protein engager and gemcitabine combination therapy Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand) Universal allogeneic CAR T cells engineered with Sleeping Beauty transposons and CRISPR-CAS9 for cancer immunotherapy Affordable Immunotherapy – Opportunities and Challenges On-demand GLUT3 expression augments CAR-T cell metabolic fitness and antitumor efficacy in glioblastoma models Affordable Immunotherapy: Opportunities and Challenges CAR T-cell Immunometabolism: Insights from Patients AP-SciBio 2027 x WIC APAC 2027 & Thai Immunology Annual Meeting Thailand Successfully Hosts Its First WIC APAC Webinar, Drawing Strong Regional Interest in Personalized Cancer Vaccines Cell Therapy for Solid Cancers: Promise or Overpromise? Antibody-Drug Conjugates (ADCs): Recent Advances in the Treatment of Solid Tumors Cell Therapy for Solid Cancers – Promise or Overpromise? Personalized Cancer Vaccines – A New Frontier in Thailand’s Fight Against Cancer Member Contents Our Team TTCI Representative Highlights CAR-T Cell Therapy Roadmap at the 74th JSTMCT Annual Meeting in Yokohama TTCI Researchers Present and Collaborate at the 29th Annual Meeting of the Japanese Association of Cancer Immunology Basic Cancer Immunology for Clinicians A Trispecific Antibody Induces Potent Tumor-Directed T-Cell Activation and Antitumor Activity by CD3/CD28 Co-Engagement CAR T-cell therapy for paediatric solid tumours: clinical trial development and preclinical modelling CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML TTCI at a glance TTCI to Participate in WIC-APAC 2026 Chiang Mai University Team Efficiently targeting folate receptor alpha-positive ovarian cancer by human antibody VH domain-based chimeric antigen receptor (CAR) Antibody-Drug Conjugates (ADCs) – Recent Advances in the Treatment of Solid Tumors Mahidol University Team Equipment NRCT Hosts Seminar on “Thai Cancer Immunotherapy: Collaboration, Regulation, and the Future of Treatment” at MHESI Fair 2025 Scientific Meeting: Medical Applications of Gene Editing and Synthetic Biology Technologies Thai Immunology Annual Meeting 2026 IPOPI | SEAPID | Chulalongkorn | Erasmus MC Meeting 2026 White Paper Pediatric Neuro-Oncology Consortium – Chulalongkorn University Research Forum Government Agencies and Related Announcements IMMUNOLOGY SEMINAR: PEPTIDE CANCER VACCINE EXPERIENCE AT NCI Registration Open: 1st International Scientific Symposium in Hematologic Malignancy (CETH, Chulalongkorn University) Khonkaen University Team University of Wisconsin School of Medicine and Public Health Antitumor activities of chimeric antigen receptor T cells targeting Mucin-1 with self-released anti-PD-1 IgG antibody A multi-center clinical research project to study the Safety and Efficacy of CD19 CAR T-cells in ALL (Acute Lymphoblastic Leukemia) by Academic Hubs Antitumor activities of chimeric antigen receptor T cells targeting Mucin-1 with self-released anti-PD-1 IgG antibody TTCI Members Receive Research Recognition Awards from Faculty of Sciences, Chiang Mai University Celebrating Excellence in Immunotherapy: Dr. Piriya Luangwattananun Honored as Young Investigator TTCI Webinar “CAR T-cell Immunometabolism, Insights from Patients” Patient Care and Toxicities Management of CAR T-cell in Pediatrics Thammasat University Team Chulalongkorn University Team International Collaborator On-demand GLUT3 expression augments CAR-T cell metabolic fitness and antitumor efficacy in glioblastoma models